Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Bioscience, Biotechnology, and Biochemistry|April 19, 2016
Phenotypes of gene disruptants in relation to a putative mitochondrial malate-citrate shuttle protein in citric acid-producing Aspergillus nigerKohtaro Kirimura, Keiichi Kobayashi, Yuka Ueda, et al.
Japanese Journal of Clinical Oncology|December 25, 2007
Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomideMotoo Nagane, Keiichi Kobayashi, Akiko Ohnishi, et al.
The FEBS Journal|August 22, 2015
Enzymatic characterization and gene identification of aconitate isomerase, an enzyme involved in assimilation of trans-aconitic acid, from Pseudomonas sp. WU-0701Kahori Yuhara, Hiromi Yonehara, Takasumi Hattori, et al.
Journal of Neurosurgery. Case Lessons|October 6, 2025
Aspiration prevention surgeries for adult patients with brainstem malignant gliomas: illustrative casesKensuke Ikeda, Kuniaki Saito, Nobuyoshi Sasaki, et al.
Rinsho Shinkeigaku = Clinical Neurology|December 18, 2008
[Brainstem variant of reversible posterior leukoencephalopathy syndrome with a prolonged clinical course: a case report]Chizuko Oishi, Haruko Okano, Kazuya Uegama, et al.
Neurosurgery|April 3, 2008
Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cellsKeiichi Kobayashi, Akiko Ohnishi, Jutabha Promsuk, et al.
International Journal of Pediatric Otorhinolaryngology|March 15, 2005
Survey of the present status of sleep-disordered breathing in children with achondroplasia Part I. A questionnaire surveyKieko Onodera, Hideaki Sakata, Naoko Niikuni, et al.
International Journal of Clinical Oncology|January 29, 2013
Predictive significance of mean apparent diffusion coefficient value for responsiveness of temozolomide-refractory malignant glioma to bevacizumab: preliminary reportMotoo Nagane, Keiichi Kobayashi, Masaki Tanaka, et al.
ACS Applied Materials & Interfaces|October 21, 2025
Preparation and Antiviral Activity of La<sub>2</sub>CuO<sub>4</sub> and Y<sub>2</sub>Cu<sub>2</sub>O<sub>5</sub> with Mechanistic Insights from First-PrinciplesRyuju Kiribayashi, Kayano Sunada, Toshihiro Isobe, et al.
Japanese Journal of Clinical Oncology|September 5, 2020
Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation statusYusuke Tabei, Keiichi Kobayashi, Kuniaki Saito, et al.
Pageof 5